JP2008525513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525513A5 JP2008525513A5 JP2007548747A JP2007548747A JP2008525513A5 JP 2008525513 A5 JP2008525513 A5 JP 2008525513A5 JP 2007548747 A JP2007548747 A JP 2007548747A JP 2007548747 A JP2007548747 A JP 2007548747A JP 2008525513 A5 JP2008525513 A5 JP 2008525513A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- compound
- formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04380279A EP1676844A1 (en) | 2004-12-28 | 2004-12-28 | 5-HT7 receptor antagonists |
| US11/048,992 US7345057B2 (en) | 2004-12-28 | 2005-02-02 | 5-HT7 receptor antagonists |
| PCT/EP2005/014046 WO2006069776A1 (en) | 2004-12-28 | 2005-12-27 | 5-ht7 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525513A JP2008525513A (ja) | 2008-07-17 |
| JP2008525513A5 true JP2008525513A5 (enExample) | 2009-02-12 |
Family
ID=34931894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548747A Pending JP2008525513A (ja) | 2004-12-28 | 2005-12-27 | ５−ｈｔ７受容体拮抗薬 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7345057B2 (enExample) |
| EP (2) | EP1676844A1 (enExample) |
| JP (1) | JP2008525513A (enExample) |
| KR (1) | KR20070091040A (enExample) |
| CN (1) | CN101090898A (enExample) |
| AU (1) | AU2005321463A1 (enExample) |
| BR (1) | BRPI0519792A2 (enExample) |
| CA (1) | CA2590666A1 (enExample) |
| MX (1) | MX2007007894A (enExample) |
| RU (1) | RU2007128926A (enExample) |
| WO (1) | WO2006069776A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005274927B2 (en) | 2004-07-15 | 2011-11-03 | Albany Molecular Research, Inc. | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| WO2008064329A1 (en) * | 2006-11-21 | 2008-05-29 | University Of Tennessee Research Foundation | Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
| DK2155717T3 (da) * | 2007-05-11 | 2012-11-19 | Lilly Co Eli | 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl-pyraziner og -pyridiner og 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl-pyridiner som 5-ht7-receptorantagonister |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| EP2375899B1 (en) * | 2009-01-12 | 2015-02-25 | Array Biopharma Inc. | Piperidine-containing compounds and use thereof in the treatment of diabetes |
| US8802696B2 (en) * | 2009-05-12 | 2014-08-12 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof |
| WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
| CN102458123A (zh) * | 2009-05-12 | 2012-05-16 | 阿尔巴尼分子研究公司 | 芳基、杂芳基和杂环取代的四氢异喹啉及其用途 |
| GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
| US10208016B2 (en) | 2013-06-21 | 2019-02-19 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
| GB201420095D0 (en) | 2014-11-12 | 2014-12-24 | Takeda Pharmaceutical | New use |
| US11505529B2 (en) * | 2017-03-03 | 2022-11-22 | National Taiwan University | 8-phenyl-isoquinolines and pharmaceutical composition thereof used in the treatment of irritable bowel syndrome |
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| WO2021021979A2 (en) | 2019-07-30 | 2021-02-04 | Eikonizo Therapapeutics, Inc. | Hdac6 inhibitors and uses thereof |
| CN112083107B (zh) * | 2020-09-28 | 2022-07-05 | 中国计量科学研究院 | 检测蜂蜜基质中磺胺类药物葡萄糖醛酸结合物的方法 |
| EP4504190A4 (en) | 2022-04-08 | 2026-03-25 | Eikonizo Therapeutics Inc | OXADIAZOLE HDAC6 INHIBITORS AND THEIR USES |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ193654A (en) | 1979-05-16 | 1984-08-24 | Wuelfing Johann A | Naphthalene sulphonamido-alkyl-piperidines,pyrrolidines or piperazines and pharmaceutical compositions |
| EP0076072B1 (en) | 1981-09-24 | 1987-05-13 | BEECHAM - WUELFING GmbH & Co. KG | Sulphonamides |
| WO1997029097A1 (en) | 1996-02-09 | 1997-08-14 | Smithkline Beecham Plc | Sulfonamide derivatives as 5ht7 receptor antagonists |
| GB9612884D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| WO1997049695A1 (en) * | 1996-06-25 | 1997-12-31 | Smithkline Beecham P.L.C. | Sulfonamide derivatives as 5ht7 receptor antagonists |
| AU1558899A (en) | 1997-11-10 | 1999-05-31 | F. Hoffmann-La Roche Ag | Isoquinoline derivatives for use against cns disorders |
| WO2000000472A1 (en) * | 1998-06-30 | 2000-01-06 | Du Pont Pharmaceuticals Company | 5-ht7 receptor antagonists |
| GB0128885D0 (en) | 2001-12-03 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
-
2004
- 2004-12-28 EP EP04380279A patent/EP1676844A1/en not_active Withdrawn
-
2005
- 2005-02-02 US US11/048,992 patent/US7345057B2/en not_active Expired - Fee Related
- 2005-12-27 CN CNA2005800452243A patent/CN101090898A/zh active Pending
- 2005-12-27 MX MX2007007894A patent/MX2007007894A/es not_active Application Discontinuation
- 2005-12-27 EP EP05849072A patent/EP1831195B1/en not_active Expired - Lifetime
- 2005-12-27 JP JP2007548747A patent/JP2008525513A/ja active Pending
- 2005-12-27 CA CA002590666A patent/CA2590666A1/en not_active Abandoned
- 2005-12-27 BR BRPI0519792-9A patent/BRPI0519792A2/pt not_active IP Right Cessation
- 2005-12-27 AU AU2005321463A patent/AU2005321463A1/en not_active Abandoned
- 2005-12-27 KR KR1020077017187A patent/KR20070091040A/ko not_active Withdrawn
- 2005-12-27 RU RU2007128926/04A patent/RU2007128926A/ru not_active Application Discontinuation
- 2005-12-27 WO PCT/EP2005/014046 patent/WO2006069776A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010520869A5 (enExample) | ||
| JP2008524328A5 (enExample) | ||
| JP2008133297A5 (enExample) | ||
| WO2010129467A1 (en) | Compounds and methods for inhibition of renin, and indications therefor | |
| KR20060027338A (ko) | 벤즈 아미드 유도체 또는 그 염 | |
| JPWO2012102254A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| JP2009538358A (ja) | 脂肪酸アミド加水分解酵素のオキサゾリルピペリジン・モジュレーター | |
| JP2008505107A5 (enExample) | ||
| JP2007015928A (ja) | 新規オレフィン誘導体 | |
| JP2015178458A (ja) | ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩 | |
| JP2010504351A5 (enExample) | ||
| CA2570197A1 (en) | Nk1 antagonists | |
| RU2582337C2 (ru) | Производные триазола в качестве лигандов рецепторов гамк | |
| US7671056B2 (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor | |
| JP2004507527A5 (enExample) | ||
| WO2011013624A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| RU2007128926A (ru) | Антагонисты 5ht7 рецепторов | |
| JP2008525512A5 (enExample) | ||
| JP6943239B2 (ja) | Ｋｃｎｑ２〜５チャネル活性化剤 | |
| JP2005528367A5 (enExample) | ||
| CA2720461C (en) | Classes of gabaa/bzr ligands | |
| JP3887785B2 (ja) | ５−ｈｔ２レセプター親和性を有する置換四環状オキサゼピン及びチアゼピン誘導体 | |
| WO2014017342A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| JPWO2006132438A1 (ja) | １，３−ベンゾチアジノン誘導体およびその用途 | |
| JP2006523223A5 (enExample) |